During the last session, ProQR Therapeutics N.V (NASDAQ:PRQR)’s traded shares were 0.32 million, with the beta value of the company hitting 0.32. At the end
In the last trading session, 1.03 million shares of the ProQR Therapeutics N.V (NASDAQ:PRQR) were traded, and its beta was 0.33. Most recently the company’s
In the last trading session, 1.17 million ProQR Therapeutics N.V (NASDAQ:PRQR) shares changed hands as the company’s beta touched 0.36. With the company’s per share
During the last session, ProQR Therapeutics N.V (NASDAQ:PRQR)’s traded shares were 0.46 million, with the beta value of the company hitting 0.46. The 52-week high
ProQR Therapeutics N.V (NASDAQ:PRQR)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.47. At the close of
In last trading session, ProQR Therapeutics N.V (NASDAQ:PRQR) saw 0.56 million shares changing hands with its beta currently measuring 0.41. Company’s recent per share price
During the last session, ProQR Therapeutics N.V (NASDAQ:PRQR)’s traded shares were 0.32 million, with the beta value of the company hitting 0.19. At the end
ProQR Therapeutics N.V (NASDAQ:PRQR)’s traded shares stood at 0.63 million during the last session, with the company’s beta value hitting 0.16. At the close of
ProQR Therapeutics N.V (NASDAQ:PRQR)’s traded shares stood at 2.32 million during the last session, with the company’s beta value hitting 0.16.The PRQR share’s 52-week high
In last trading session, ProQR Therapeutics N.V (NASDAQ:PRQR) saw 0.61 million shares changing hands with its beta currently measuring 0.18. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
